178 related articles for article (PubMed ID: 27931301)
1. Corticosteroid-related toxicity in patients with chronic idiopathic urticariachronic spontaneous urticaria.
Ledford D; Broder MS; Antonova E; Omachi TA; Chang E; Luskin A
Allergy Asthma Proc; 2016 Nov; 37(6):458-465. PubMed ID: 27931301
[TBL] [Abstract][Full Text] [Related]
2. Health care burden and treatment patterns in commercially insured children with chronic idiopathic/spontaneous urticaria: A real-world study in the United States.
Williams P; Kavati A; Pilon D; Xiao Y; Zhdanava M; Balp MM; Lefebvre P; Ortiz B; Hernandez-Trujillo V
Allergy Asthma Proc; 2018 May; 39(3):201-211. PubMed ID: 29514728
[TBL] [Abstract][Full Text] [Related]
3. Cost, utilization, and patterns of medication use associated with chronic idiopathic urticaria.
Zazzali JL; Broder MS; Chang E; Chiu MW; Hogan DJ
Ann Allergy Asthma Immunol; 2012 Feb; 108(2):98-102. PubMed ID: 22289728
[TBL] [Abstract][Full Text] [Related]
4. Resource use and costs in an insured population of patients with chronic idiopathic/spontaneous urticaria.
Broder MS; Raimundo K; Antonova E; Chang E
Am J Clin Dermatol; 2015 Aug; 16(4):313-321. PubMed ID: 26055728
[TBL] [Abstract][Full Text] [Related]
5. Treatment Patterns, Healthcare Resource Utilization, and Spending Among Medicaid-Enrolled Children with Chronic Idiopathic/Spontaneous Urticaria in the United States.
Williams PV; Kavati A; Pilon D; Xiao Y; Zhdanava M; Balp MM; Lefebvre P; Ortiz B; Hernandez-Trujillo V
Dermatol Ther (Heidelb); 2018 Mar; 8(1):69-83. PubMed ID: 29429043
[TBL] [Abstract][Full Text] [Related]
6. Validation of an ICD-9-based claims algorithm for identifying patients with chronic idiopathic/spontaneous urticaria.
Cherepanov D; Raimundo K; Chang E; Eagan M; Zazzali JL; Solari PG; DeCotiis B; Hussain I; Rehman SM; Shahab N; Tilles SA; Broder MS
Ann Allergy Asthma Immunol; 2015 May; 114(5):393-8. PubMed ID: 25771155
[TBL] [Abstract][Full Text] [Related]
7. Real-world use of omalizumab in patients with chronic idiopathic/spontaneous urticaria in the United States.
Eghrari-Sabet J; Sher E; Kavati A; Pilon D; Zhdanava M; Balp MM; Lefebvre P; Ortiz B; Bernstein JA
Allergy Asthma Proc; 2018 May; 39(3):191-200. PubMed ID: 29458456
[TBL] [Abstract][Full Text] [Related]
8. Effect of chronic urticaria on US patients: analysis of the National Health and Wellness Survey.
Vietri J; Turner SJ; Tian H; Isherwood G; Balp MM; Gabriel S
Ann Allergy Asthma Immunol; 2015 Oct; 115(4):306-11. PubMed ID: 26265010
[TBL] [Abstract][Full Text] [Related]
9. Effects of Helicobacter pylori Eradication in Chronic Spontaneous Urticaria: Results from a Retrospective Cohort Study.
Curth HM; Dinter J; Nigemeier K; Kütting F; Hunzelmann N; Steffen HM
Am J Clin Dermatol; 2015 Dec; 16(6):553-8. PubMed ID: 26334425
[TBL] [Abstract][Full Text] [Related]
10. Clinical-laboratory characteristics of ANA-positive chronic idiopathic urticaria.
Magen E; Waitman DA; Dickstein Y; Davidovich V; Kahan NR
Allergy Asthma Proc; 2015; 36(2):138-44. PubMed ID: 25715242
[TBL] [Abstract][Full Text] [Related]
11. Risk of corticosteroid-related adverse events in asthma patients with high oral corticosteroid use.
Zazzali JL; Broder MS; Omachi TA; Chang E; Sun GH; Raimundo K
Allergy Asthma Proc; 2015; 36(4):268-74. PubMed ID: 26108084
[TBL] [Abstract][Full Text] [Related]
12. Clinical and laboratory features of antihistamine-resistant chronic idiopathic urticaria.
Magen E; Mishal J; Zeldin Y; Schlesinger M
Allergy Asthma Proc; 2011; 32(6):460-6. PubMed ID: 22221441
[TBL] [Abstract][Full Text] [Related]
13. Medication patterns in chronic spontaneous urticaria: results from a nationwide investigation in the primary care setting in Italy.
Vena GA; Cassano N; Pegoraro V; Cataldo N; Heiman F; Cricelli I; Colombo D; Zagni E; Cricelli C; Lapi F
G Ital Dermatol Venereol; 2018 Feb; 153(1):39-42. PubMed ID: 27248148
[TBL] [Abstract][Full Text] [Related]
14. Use of Dapsone in the Treatment of Chronic Idiopathic and Autoimmune Urticaria.
Liang SE; Hoffmann R; Peterson E; Soter NA
JAMA Dermatol; 2019 Jan; 155(1):90-95. PubMed ID: 30476976
[TBL] [Abstract][Full Text] [Related]
15. Effect of arterial hypertension on chronic urticaria duration.
Nebiolo F; Bergia R; Bommarito L; Bugiani M; Heffler E; Carosso A; Castiglioni G; Guida G; Badiu I; Pizzimenti S; Mietta S; Ferrero N; Rolla G
Ann Allergy Asthma Immunol; 2009 Nov; 103(5):407-10. PubMed ID: 19927539
[TBL] [Abstract][Full Text] [Related]
16. Prognosis of chronic spontaneous urticaria in 117 patients not controlled by a standard dose of antihistamine.
Hiragun M; Hiragun T; Mihara S; Akita T; Tanaka J; Hide M
Allergy; 2013 Feb; 68(2):229-35. PubMed ID: 23205732
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of omalizumab in chronic spontaneous urticaria assessed with patient-reported outcomes: a prospective study.
Ghazanfar MN; Holm JG; Thomsen SF
J Eur Acad Dermatol Venereol; 2018 Oct; 32(10):1761-1767. PubMed ID: 29729103
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology and comorbidities of patients with chronic urticaria in Korea: A nationwide population-based study.
Kim BR; Yang S; Choi JW; Choi CW; Youn SW
J Dermatol; 2018 Jan; 45(1):10-16. PubMed ID: 28983950
[TBL] [Abstract][Full Text] [Related]
19. Health care resource use and costs associated with possible side effects of high oral corticosteroid use in asthma: a claims-based analysis.
Luskin AT; Antonova EN; Broder MS; Chang EY; Omachi TA; Ledford DK
Clinicoecon Outcomes Res; 2016; 8():641-648. PubMed ID: 27822075
[TBL] [Abstract][Full Text] [Related]
20. Management of chronic inducible urticaria according to the guidelines: A prospective controlled study.
Kocatürk E; Can PK; Akbas PE; Copur M; Degirmentepe EN; Kızıltac K; Singer R
J Dermatol Sci; 2017 Jul; 87(1):60-69. PubMed ID: 28314658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
